MMP2 also activates TGF-β to promote epithelial-mesenchymal transformation (EMT), while by releasing vascular endothelial growth factor (VEGF), MMP9 promotes tumor angiogenesis (33, 34). The gene discussed is VEGFA; the disease is neoplasm.